EcoDrugPlus

Integrin, Beta 1a

Ensembl ID : ENSSMAG00000002905
Gene Symbol: ITGB1A
3 Cross references
213 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSSMAG00000012180
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSSMAG00000007871
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSSMAG00000011742
Gene Symbol: LOC118313125
3 Cross references
183 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSSMAG00000017961
Gene Symbol: LOC118289399
2 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSMAG00000014096
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSSMAG00000001429
Gene Symbol: IDH2
3 Cross references
207 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSSMAG00000014257
Gene Symbol: KDR
1 Cross references
196 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSMAG00000003556
Gene Symbol: KIF5B
1 Cross references
234 Possible Orthologues:

Kinesin-1 Heavy Chain

Ensembl ID : ENSSMAG00000007536
Gene Symbol: LOC118310583
2 Cross references
236 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSSMAG00000010983
Gene Symbol: LGALS3A
1 Cross references
220 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSSMAG00000014120
Gene Symbol: LTB4R
2 Cross references
142 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).